ISRCTN70358598CompletedNot Applicable
The Use of Proton Pump Inhibitors in General Practice
HS R&D Regional Programme Register - Department of Health (UK)0 sites0 target enrollmentStarted: January 23, 2004Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Not provided at time of registration
Exclusion Criteria
- •Not provided at time of registration
Investigators
Similar Trials
Not yet recruiting
Not Applicable
The failure of Proton Pump Inhibitors in Gastro Esophageal Reflux DiseaseGERDheartburn10017977NL-OMON35604Academisch Medisch Centrum24
Active, not recruiting
Phase 1
Clinical trial to reduce the severity of organ dysfunction and in-vitro experiments to identify specific hallmarks in septic patients’ monocytes and to characterize the mechanism of action of PPI (PPI-SEPSIS)Sepsis is a severe disease with a high mortality rate and lack of efficacious therapiesMedDRA version: 20.0Level: PTClassification code 10040047Term: SepsisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2018-000488-98-ITOSPEDALE SAN RAFFAELE300
Unknown
Not Applicable
Research on the effect of a proton pump inhibitor on the oral and intestinal microbiota and salivary protein and metabolites.healthy volunteerJPRN-UMIN000025331Shimane university24
Completed
Not Applicable
The influence of proton pump inhibitor therapy on the clinical course of COVID-19SARS-CoV2J12.8J80.0Other viral pneumoniaDRKS00021523niversitätsklinikum Freiburg, Klinik für Innere Medizin II152
Completed
Not Applicable
Efficiency of Proton pump Inhibitors in Patients with gastro-oesophageal reflux symptomsGastro-oesophageal reflux diseaseDigestive SystemGI tract disordersISRCTN68985072Erasmus Medical Center (The Netherlands)415